Codexis
CDXS
Codexis (CDXS) news
Recent news
Codexis enters into an agreement with pioneering Sirna drug innovator to leverage the Eco synthesis manufacturing platform to create stereo-defined siRNA
AInvest Wire · Sep 28, 2026Codexis, Inc.: Company reiterates full-year financial guidance
AInvest Wire · Aug 11, 2026Codexis 2Q loss/share 13c
AInvest Wire · Aug 11, 2026Codexis still sees FY revenue $72M to $76M, estimated $74.1M
AInvest Wire · Aug 11, 2026Codexis 2026 financial guidance reiterated
AInvest Wire · Aug 11, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.
